CLICK HERE TO VIEW CURRENT ISSUE

Stay Informed
with these

Services
Agri Marketing Update
e-newsletter sent each Monday and Thursday
Agri Marketing
Text Alerts

Big news as it breaks
@AgriMarketing on Twitter
Farm Show Guide
Marketing Services Guide
Books:

National Agri-Marketing Association
NAMA Website
Upcoming Events
Chapters
Agri-Marketing Conf
Best of NAMA 2024












FDA RELEASE REPORT ON ANTIMICROBIAL USE IN LIVESTOCK, USAGE CONTINUES TO FALL


Feedstuffs magazine reports:

The U.S. Food and Drug Administration's Center for Veterinary Medicine published the 2021 Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals.

To read a summary of the report click here.

This year's report shows that domestic sales and distribution of medically important antimicrobial drugs approved for use in food-producing animals decreased by less than 1% between 2020 and 2021. Since the significant decrease in sales volume in 2017, annual sales of medically important antimicrobials have remained at reduced levels. Compared to 2015 (peak year of sales), 2021 sales decreased 38%.

FDA recognizes that fluctuations in sales volume may occur over time in response to various factors, including changing animal health needs or changes in animal populations.

Given the substantial change that occurred with transitioning a large number of products containing medically important antimicrobials from over-the-counter use to a marketing status requiring veterinary oversight at the beginning of 2017, some rebound in the reported sales volume in subsequent years was not unexpected as affected stakeholders adjusted to the new requirements.

To read the entire article click here.


Search News & Articles












Proudly associated with:
SIIA AM&P Canadian Agri-food Marketers Alliance National Agri-Marketing Association
Agricultural Relations Council National Association of Farm Broadcasters Agricultural Communicators Network Livestock Publications Council
All content © 2024, Henderson Communications LLC. | User Agreement